Inventor

David B. Kanne

Inventor
Corte Madera, CA, US

Overview

25→
Patents
1985–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A01Nprimary
A01NPreservation of bodies of humans or animals or plants or parts thereof20%
A61KPreparations for medical, dental or toiletry purposes16%
C07HSugars16%
C07DHeterocyclic compounds14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02ATechnologies for adaptation to climate change3%
B08BCleaning in general2%
C10MLubricating compositions2%
PatentTitleYear
11,098,077Locked nucleic acid cyclic dinucleotide compounds and uses thereof202111,040,053Compositions and methods for activating "stimulator of interferon gene"13 dependent signalling202110,906,930Compositions and methods for activating "stimulator of interferon gene"-dependent signalling202110,653,774Compositions and methods for activating "stimulator of interferon gene"-dependent signalling202010,449,211Compositions and methods for activating "stimulator of interferon gene"--dependent signalling201910,414,789Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use201910,189,873Compositions and methods for inhibiting "stimulator of interferon gene"-dependent signalling20199,724,408'Compositions and methods for activating stimulator of interferon gene-dependent signalling'20179,695,212'Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use'20179,549,944'Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling'20178,586,814'Squalane and isosqualane compositions and methods for preparing the same'20137,188,636'Containment cart'20075,763,357'3-substituted pyridine compounds and derivatives thereof'19985,714,438'Herbicidal 5-substituted pyrimidine compounds and derivatives thereof'19985,707,930'4-cycloalkyl-5-substituted pyrimidine compounds useful as crop protection agents'19985,672,567'Herbicidal hydroxybenzyl-substituted heteroaryl compounds and derivatives thereof'19975,670,453'Herbicidal hydroxybenzyl-substituted heteroaryl compounds and derivatives thereof'19975,595,958'3-substituted pyridine compounds and derivatives thereof'19975,565,413'Substituted pyridyl phenyl ketone herbicides'19965,215,998'Alkylphosphonothioate insecticides'19935,189,169'Phosphorodiamidothioate herbicides'19935,189,060'Imidate insecticides'19935,070,210'Novel ketenimines as intermediates for insecticides'19914,565,809'S-Aralkyltrithiophosphonate insecticides'19864,514,215'4-(2,6-Dialkylphenylamino)-3-alkoxy-2-butenoic acid and their use as herbicides'1985

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1985–1991Based in Richmond, CA, US· patent location history
1993Patents assigned to ICI PLC (3)· patent assignee history
1993–2021Based in Corte Madera, CA, US· patent location history
1996–1998Patents assigned to ZENECA LTD (7)· patent assignee history
1997–2021Based in Madera, CA, US· patent location history
2007Based in Carroll, IA, US· patent location history
2017–2021Patents assigned to ADURO BIOTECH INC (8)· patent assignee history
2021Patents assigned to CHINOOK THERAPEUTICS INC (3)· patent assignee history
2021Patents assigned to NOVARTIS AG (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ADURO BIOTECH INC82017–2021
ZENECA LTD71996–1998
CHINOOK THERAPEUTICS INC32021
ICI PLC31993
NOVARTIS AG22021
Locations
LocationPatentsSpan
Corte Madera, California, US191993–2021
Richmond, California, US31985–1991
Madera, California, US21997–2021
Carroll, IA, US12007